Still's disease; autoinflammation; human leukocyte antigen; systemic juvenile idiopathic arthritis
Abstract :
[en] Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P = 2.8 x 10(-17), odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P = 1.0 x 10(-5), OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed that HLA-DRB1*11 and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P = 2.7 x 10(-16), OR 2.3 (1.9, 2.8)], as was the HLA-DRB1*11-HLA-DQA1*05-HLA-DQB1*03 haplotype [6.4 x 10(-17), OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.
Petty RE, et al.; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31(2):390-392.
Woo P (2006) Systemic juvenile idiopathic arthritis: Diagnosis, management, and outcome. Nat Clin Pract Rheumatol 2(1):28-34.
Martini A (2012) Systemic juvenile idiopathic arthritis. Autoimmun Rev 12(1):56-59.
Schulert GS, Grom AA (2015) Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies. Annu Rev Med 66:145-159.
Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34(5):1133-1138.
Gattorno M, et al. (2008) The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 58(5):1505-1515.
Ruperto N, et al.; Paediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group (2008) Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 372(9636):383-391.
Record JL, Beukelman T, Cron RQ (2011) Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: A retrospective case series. J Rheumatol 38(1):180-181.
Schneider R, De Benedetti F (2011) Systemic juvenile idiopathic arthritis. Textbook of Pediatric Rheumatology, eds Cassidy JT, Petty RE, Laxer RM, Lindsley CB (Saunders, Philadelphia), pp 236-248.
Thierry S, Fautrel B, Lemelle I, Guillemin F (2014) Prevalence and incidence of juvenile idiopathic arthritis: A systematic review. Joint Bone Spine 81(2):112-117.
Bedford PA, Ansell BM, Hall PJ, Woo P (1992) Increased frequency of DR4 in systemic onset juvenile chronic arthritis. Clin Exp Rheumatol 10(2):189-193.
Date Y, et al. (1999) Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 42(12):2577-2582.
Desaymard C, et al. (1996) Major histocompatibility complex markers and disease heterogeneity in one hundred eight patients with systemic onset juvenile chronic arthritis. Rev Rhum Engl Ed 63(1):9-16.
Hollenbach JA, et al. (2010) Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum 62(6):1781-1791.
Miller ML, et al. (1985) HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 28(2):146-150.
Thomson W, et al.; British Paediatric Rheumatology Study Group (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41(10):1183-1189.
Mellins ED, Macaubas C, Grom AA (2011) Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions. Nat Rev Rheumatol 7(7):416-426.
Rigante D, Cantarini L (2014) The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: Comment on the review by Nigrovic. Arthritis Rheumatol 66(9):2645.
Prahalad S, et al. (2012) Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope. Arthritis Rheum 64(3):925-930.
Jones EY, Fugger L, Strominger JL, Siebold C (2006) MHC class II proteins and disease: A structural perspective. Nat Rev Immunol 6(4):271-282.
Raziuddin S, Bahabri S, Al-Dalaan A, Siraj AK, Al-Sedairy S (1998) A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: Immunoregulatory IL-10 function. Clin Immunol Immunopathol 86(2):192-198.
Omoyinmi E, et al. (2012) Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 51(10):1881-1886.
Haylett RS, Koch N, Rink L (2009) MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells. Eur J Immunol 39(7):1947-1955.
Liu X, et al. (2011) Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 12(5):416-424.
Andreae S, Buisson S, Triebel F (2003) MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102(6):2130-2137.
Kissner TL, et al. (2011) Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules. PLoS One 6(1):e15985.
Trede NS, Geha RS, Chatila T (1991) Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands. J Immunol 146(7):2310-2315.
